Biocept CEO Michael Nall's 2018 pay falls 61% to $440K

Biocept reports 2018 executive compensation

By ExecPay News

Published: April 30, 2019

Biocept reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three Biocept executives received on average a compensation package of $362K, a 53% decrease compared to previous year.
Average pay of disclosed executives at Biocept
Michael W. Nall, Chief Executive Officer, received $440K in total, which decreased by 61% compared to 2017. 97% of Nall's compensation, or $426K, was in salary. Nall also received $13K in other compensation.
Timothy C. Kennedy, Chief Financial Officer, received a compensation package of $359K, which decreased by 42% compared to previous year. 96% of the compensation package, or $346K, was in salary.
Lyle J. Arnold, Chief Scientific Officer, earned $287K in 2018, a 48% decrease compared to previous year.

Related executives

Michael Nall

Biocept

Chief Executive Officer

Timothy Kennedy

Biocept

Chief Financial Officer

Lyle Arnold

Biocept

Chief Scientific Officer

You may also like

Source: SEC filing on April 30, 2019.